
Opinion|Videos|December 23, 2024
Rosie’s Journey with R/R MM
This segment explores the treatment journey of a 55-year-old mother and high school teacher with ALK-positive NSCLC and brain metastases, focusing on her experience with lorlatinib therapy.
Advertisement
This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of patients with R/R MM as seen in clinical practice. The hypothetical case was co-developed by staff Medical Writers with Cancer Network/ONN.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel 4-Biomarker Panel Improves Early Detection of Pancreatic Cancer
2
Bria-IMT Continues to Improve Survival in Metastatic Breast Cancer
3
Heavy, Consistent Alcohol Intake Increases Risk of Colorectal Cancer
4
FDA Type B Meeting Elucidates Testosterone-Associated Breast Cancer Risks
5


































